ASX Penny Stocks To Watch In August 2026

The Australian stock market is poised for a positive start to the week, buoyed by encouraging developments from Wall Street, despite recent fluctuations in the S&P/ASX 200 index and an uptick in unemployment rates. For investors eyeing smaller or newer companies, penny stocks—though the term may seem outdated—remain a viable investment area offering potential value. By focusing on those with strong financials and solid fundamentals, investors can uncover opportunities for growth at lower price points without many of the typical risks associated with this sector.

Below we spotlight a couple of our favorites from our exclusive screener.

Finbar Group (ASX:FRI)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Finbar Group Limited, along with its subsidiaries, operates in the property development and investment sector in Australia and has a market capitalization of A$206.81 million.

Operations: The company's revenue is primarily derived from its Residential Apartment Development segment, which generated A$151.23 million, followed by Commercial Office/Retail Development at A$14.07 million and Rental of Property contributing A$9.46 million.

Market Cap: A$206.81M

Finbar Group Limited, with a market capitalization of A$206.81 million, primarily generates revenue from its Residential Apartment Development segment. The company has managed to cover its debt well through operating cash flow and maintains more cash than total debt. However, recent earnings growth has been negative, contrasting with significant profit growth over the past five years. Finbar's price-to-earnings ratio suggests it is undervalued compared to the broader Australian market. Despite an unstable dividend history and low return on equity at 6.1%, the company's short-term assets comfortably cover both its short and long-term liabilities.

• Click here to discover the nuances of Finbar Group with our detailed analytical financial health report.
• Gain insights into Finbar Group's past trends and performance with our report on the company's historical track record.

Hamelin Gold (ASX:HMG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Hamelin Gold Limited is a mineral exploration company active in the Western Tanami and Yilgarn regions of Western Australia, with a market capitalization of A$51.56 million.

Operations: Hamelin Gold Limited has not reported any specific revenue segments.

Market Cap: A$51.56M

Hamelin Gold Limited, with a market capitalization of A$51.56 million, is pre-revenue and unprofitable, facing increased losses over the past five years. The company has no debt and short-term assets of A$3.7 million exceed its liabilities. Recently, Hamelin raised A$8 million through a follow-on equity offering to bolster its cash runway beyond the current 12 months based on free cash flow estimates. Despite high volatility in its share price and negative return on equity at -23.42%, shareholders have not faced meaningful dilution recently, while the board maintains an average tenure of 5.1 years indicating experience.

• Navigate through the intricacies of Hamelin Gold with our comprehensive balance sheet health report here.
• Review our historical performance report to gain insights into Hamelin Gold's track record.

Zeotech (ASX:ZEO)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Zeotech Limited is involved in the exploration and evaluation of mineral properties in Australia, with a market cap of A$178.99 million.

Operations: The company generates revenue of A$1.24 million from activities related to the exploration, evaluation, and associated processes of minerals.

Market Cap: A$178.99M

Zeotech Limited, with a market cap of A$178.99 million, is pre-revenue and unprofitable, experiencing increased losses at 10.2% annually over five years. Despite this, it maintains a strong financial position with A$12.6 million in short-term assets exceeding both short-term and long-term liabilities. The company is debt-free and has a cash runway extending beyond two years if current free cash flow trends persist. While the management team's average tenure of 1.9 years suggests inexperience, the board's longer tenure of 6.1 years reflects stability amidst stable weekly volatility in its share price over the past year.

• Unlock comprehensive insights into our analysis of Zeotech stock in this financial health report.
• Understand Zeotech's track record by examining our performance history report.

Key Takeaways

• Click through to start exploring the rest of the 400 ASX Penny Stocks now.
• Ready For A Different Approach? These 21 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com